SHEBA MEDICAL CENTER
🇿🇦South Africa
- Country
- 🇿🇦South Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01320436
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
Virtual Reality Intervention for Stroke Rehabilitation
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-25
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT01304017
The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01290159
- Locations
- 🇮🇱
Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer, Israel
Central Hypothyroidism, a Novel Laboratory Measurement
Not Applicable
- Conditions
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2011-02-03
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01280292
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2011-01-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01280305
- Locations
- 🇷🇴
Spitalul de Psihiatrie Botosani, Botosani, Romania
🇷🇴Spitalul Clinic de Psihiatrie "Prof. Dr. Alex. Obregia", Bucuresti, Romania
🇷🇴Sp. Jud. "Prof. Dr.O. Fodor", Cluj-Napoca, Romania
Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2011-01-07
- Last Posted Date
- 2011-01-07
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT01272310
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2013-12-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 34
- Registration Number
- NCT01256697
- Locations
- 🇮🇱
Sheba Medical Center, Tel Hashomer, Israel
Saline Injection - Assisted Anesthesia in Eyelid Surgery
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2011-08-09
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01239498
- Locations
- 🇮🇱
Goldschlager eye institute, Ramat Gan, Israel
🇮🇱Goldschleger institute of ophthalmology, Sheba medical center, Ramat Gan, Israel
Injectable Collagenase For Burns' Associated Contracture
- First Posted Date
- 2010-11-10
- Last Posted Date
- 2010-11-10
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01237964
- Locations
- 🇮🇱
Sheba Hospital, Ramat Gan, Israel
Diagnosis of Posttraumatic Stress Disorder Following Primary Rhegmatogenous Retinal Detachment
Completed
- Conditions
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2010-11-03
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 547
- Registration Number
- NCT01233908
- Locations
- 🇮🇱
Goldschleger institute of ophthalmology, Sheba medical center, Ramat Gan, Israel
© Copyright 2024. All Rights Reserved by MedPath